Hikma Pharmaceuticals (OTCMKTS:HKMPY) Trading Up 1% – Time to Buy?

Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPYGet Free Report) were up 1% during mid-day trading on Thursday . The company traded as high as $50.50 and last traded at $50.50. Approximately 2,107 shares traded hands during mid-day trading, an increase of 85% from the average daily volume of 1,136 shares. The stock had previously closed at $50.00.

Hikma Pharmaceuticals Stock Up 0.1 %

The business has a 50 day moving average price of $49.11 and a 200-day moving average price of $50.02.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

Featured Stories

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.